128 related articles for article (PubMed ID: 5131995)
1. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis].
Filipecki S; Dabrowska B; Szczepański A; Glyda J
Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995
[No Abstract] [Full Text] [Related]
2. [Penicillamine in the treatment of scleroderma].
Kobíková M; Stáva Z
Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
[No Abstract] [Full Text] [Related]
3. [Proteinuria in immunopathological diseases during long-term penicillamine therapy (author's transl)].
Hrncír Z; Tichý M
Cas Lek Cesk; 1976 May; 115(18):549-51. PubMed ID: 1277236
[No Abstract] [Full Text] [Related]
4. Penicillamine for scleroderma.
Fulghum DD; Katz R
Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
[No Abstract] [Full Text] [Related]
5. [D-penicillamine in the treatment of progressive systemic sclerosis].
Marques Neto JF; Manzato LC; Samara AM
AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
[No Abstract] [Full Text] [Related]
6. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
Bluestone R; Grahame R; Holloway V; Holt PJ
Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
[No Abstract] [Full Text] [Related]
7. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
[TBL] [Abstract][Full Text] [Related]
8. [Effects and adverse effects of D-penicillamine].
Perings E; Junge U
Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780
[No Abstract] [Full Text] [Related]
9. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
Kahl LE; Medsger TA; Klein I
J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
Böni A; Pavelka K; Kludas M
Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
[No Abstract] [Full Text] [Related]
11. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
Shapiro M; Jimenez S; Werth VP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
[TBL] [Abstract][Full Text] [Related]
12. [Nephropathy in a patient with systemic scleroderma treated with D-penicillamine].
Balabanova RM; Ivanova MM; Oskilko TG
Ter Arkh; 1980; 52(4):119-21. PubMed ID: 7404326
[No Abstract] [Full Text] [Related]
13. Penicillamine for systemic sclerosis?
Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492
[No Abstract] [Full Text] [Related]
14. [D-penicillamine-induced lipoid nephrosis in a patient with scleroderma].
Kitazawa K; Ohseto Y; Kawazumi H; Saito K; Shibata T; Uchida J; Yonekura M; Shiwachi S; Ito S; Sugisaki T
Ryumachi; 1982 Oct; 22(5):397-403. PubMed ID: 7157094
[No Abstract] [Full Text] [Related]
15. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
Nishikai M; Funatsu Y; Homma M
Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
[No Abstract] [Full Text] [Related]
16. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
[TBL] [Abstract][Full Text] [Related]
17. Progressive systemic sclerosis and penicillamine.
Rodnan GP
J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome induced by penicillamine.
Stein J; Smythe HA
Can Med Assoc J; 1968 Mar; 98(10):505-7. PubMed ID: 5645186
[No Abstract] [Full Text] [Related]
19. Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis.
Tsankov NK; Lazarova AZ; Vasileva SG; Obreshkova EV
Int J Dermatol; 1990 Oct; 29(8):571-4. PubMed ID: 2147020
[TBL] [Abstract][Full Text] [Related]
20. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
Derk CT; Jimenez SA
J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
